UBS Group AG - MERIDIAN BIOSCIENCE INC ownership

MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 179 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2017. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of MERIDIAN BIOSCIENCE INC
ValueSharesWeighting
Q4 2022$1,685,042
+77.7%
50,739
+68.8%
0.00%
Q3 2022$948,000
+345.1%
30,067
+329.0%
0.00%
Q2 2022$213,000
-96.3%
7,008
-96.9%
0.00%
-100.0%
Q1 2022$5,809,000
+25.3%
223,767
-1.5%
0.00%
+100.0%
Q4 2021$4,636,000
+3700.0%
227,248
+3503.7%
0.00%
Q3 2021$122,000
-31.5%
6,306
-21.3%
0.00%
Q2 2021$178,000
-80.7%
8,014
-77.1%
0.00%
Q1 2021$920,000
+46.0%
35,052
+4.1%
0.00%
Q4 2020$630,000
+28.3%
33,676
+16.5%
0.00%
Q3 2020$491,000
-35.3%
28,906
-11.3%
0.00%
Q2 2020$759,000
+169.1%
32,592
-2.9%
0.00%
Q1 2020$282,000
-49.3%
33,577
-41.1%
0.00%
Q4 2019$556,000
+52.3%
56,966
+47.9%
0.00%
Q3 2019$365,000
+82.5%
38,518
+128.8%
0.00%
Q2 2019$200,000
+49.3%
16,838
+122.0%
0.00%
Q1 2019$134,000
-67.6%
7,585
-68.1%
0.00%
Q4 2018$413,000
+43.9%
23,791
+23.6%
0.00%
Q3 2018$287,000
+34.7%
19,244
+43.5%
0.00%
Q2 2018$213,000
+62.6%
13,407
+45.3%
0.00%
Q1 2018$131,000
-22.9%
9,225
-24.0%
0.00%
Q4 2017$170,000
-28.6%
12,132
-27.0%
0.00%
Q3 2017$238,000
-96.9%
16,625
-96.6%
0.00%
-100.0%
Q2 2017$7,777,000
+3237.8%
493,744
+2821.7%
0.00%
Q1 2017$233,000
-32.5%
16,899
-13.5%
0.00%
Q4 2016$345,000
+37.5%
19,533
+50.0%
0.00%
Q3 2016$251,000
-33.1%
13,021
-32.4%
0.00%
Q2 2016$375,000
-4.8%
19,267
+0.8%
0.00%
Q1 2016$394,000
+47.0%
19,114
+46.6%
0.00%
Q4 2015$268,000
-7.6%
13,037
-23.1%
0.00%
Q3 2015$290,000
-28.2%
16,964
-21.6%
0.00%
Q2 2015$404,000
-78.4%
21,640
-77.9%
0.00%
-100.0%
Q1 2015$1,868,000
+34.4%
97,915
+15.9%
0.00%0.0%
Q4 2014$1,390,00084,5090.00%
Other shareholders
MERIDIAN BIOSCIENCE INC shareholders Q4 2017
NameSharesValueWeighting ↓
SYQUANT CAPITAL SAS 134,804$4,47711.01%
Vazirani Asset Management LLC 115,774$3,8456.51%
FIFTH LANE CAPITAL, LP 185,914$6,174,2045.56%
NEXPOINT ASSET MANAGEMENT, L.P. 1,939,075$64,396,6815.01%
Crystalline Management Inc. 244,453$8,118,2844.08%
FNY Investment Advisers, LLC 51,000$1,6932.36%
HAVENS ADVISORS LLC 26,800$890,0282.26%
Euclidean Technologies Management, LLC 62,995$2,092,0641.99%
Sand Grove Capital Management LLP 537,060$17,8361.70%
Crabel Capital Management, LLC 120,337$3,9961.45%
View complete list of MERIDIAN BIOSCIENCE INC shareholders